Corient Private Wealth’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.67M Buy
577,660
+313,902
+119% +$1.64M ﹤0.01% 1108
2025
Q4
$1.32M Buy
263,758
+167,460
+174% +$872K ﹤0.01% 1746
2025
Q3
$488K Sell
96,298
-8,774
-8% -$38.6K ﹤0.01% 1802
2025
Q2
$453K Sell
105,072
-3,714
-3% -$18.4K ﹤0.01% 1755
2025
Q1
$656K Buy
108,786
+647
+0.6% +$3.27K ﹤0.01% 1467
2024
Q4
$427K Sell
108,139
-36,025
-25% -$161K ﹤0.01% 1701
2024
Q3
$843K Sell
144,164
-28,831
-17% -$142K ﹤0.01% 1487
2024
Q2
$746K Buy
172,995
+8,579
+5% +$41.1K ﹤0.01% 1452
2024
Q1
$773K Buy
164,416
+54,601
+50% +$209K ﹤0.01% 1422
2023
Q4
$539K Buy
109,815
+4,309
+4% +$21.1K ﹤0.01% 1581
2023
Q3
$574K Sell
105,506
-71,886
-41% -$576K ﹤0.01% 1419
2023
Q2
$1.64M Buy
177,392
+43,139
+32% +$365K ﹤0.01% 964
2023
Q1
$1.12M Sell
134,253
-33,844
-20% -$374K ﹤0.01% 1042
2022
Q4
$1.87M Buy
+168,097
New +$1.95M 0.01% 724

Other funds holding MPT

Corient Private Wealth's MPT Position: Q1 2026 in Review

Corient Private Wealth increased its Medical Properties Trust (MPT) stake by 119% in Q1 2026, buying an estimated $1.64M and bringing the position to 577,660 shares worth $2.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1108.

Corient Private Wealth first reported a position in MPT in Q4 2022 and has held it in 14 quarters since. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Corient Private Wealth held 577,660 shares of Medical Properties Trust worth $2.67M as of Q1 2026.
  • Corient Private Wealth bought 313,902 Medical Properties Trust shares in Q1 2026, an estimated $1.64M.
  • Medical Properties Trust made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1108 holding.
  • Corient Private Wealth first reported a position in Medical Properties Trust in Q4 2022 and has held it in 14 quarters since.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.